Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
574.05 INR | -1.76% |
|
+0.56% | -4.75% |
Mar. 07 | Laurus Labs Gets Board Nod to Invest INR833 Million in Joint Venture Company KRKA Pharma | MT |
Mar. 06 | Laurus Labs Approves 833 Mln Rupees Investment In KRKA Pharma | RE |
Chart calendar Laurus Labs Limited
Upcoming events on Laurus Labs Limited
Past events on Laurus Labs Limited
2025-02-16 | Kotak Chasing Growth Conference |
2025-01-24 06:30 am | Q3 2025 Earnings Call |
2025-01-24 04:28 am | Q3 2025 Earnings Release |
2024-12-03 | Jefferies India Healthcare & Pharma Investor Conference |
2024-11-13 | Avendus Spark Investor Conference |
2024-10-24 07:00 am | Q2 2025 Earnings Call |
2024-10-24 05:41 am | Q2 2025 Earnings Release |
2024-09-22 | DAM Capital Pharmaceutical Investor Conference |
2024-07-25 07:30 am | Q1 2025 Earnings Call |
2024-07-25 05:24 am | Q1 2025 Earnings Release |
2024-07-11 05:30 am | Annual General Meeting |
2024-06-12 | IIFL Pharma & Healthcare Day |
2024-06-11 | Goldman Sachs Investors Field Conference |
2024-05-29 | B&K Securities Investor Conference |
2024-04-25 07:30 am | Q4 2024 Earnings Call |
2024-04-25 05:39 am | Q4 2024 Earnings Release |
2024-02-19 | Kotak Chasing Growth Conference |
2024-02-18 | Antique Build India New India Conference |
2024-01-24 06:30 am | Q3 2024 Earnings Call |
2024-01-24 04:58 am | Q3 2024 Earnings Release |
Past dividends on Laurus Labs Limited
2024-11-05 | Interim Payment 0.4 INR |
2024-05-07 | Interim Payment 0.4 INR |
2023-11-01 | Interim Payment 0.4 INR |
2023-05-09 | Interim Payment 1.2 INR |
2022-11-02 | Interim Payment 0.8 INR |
2022-05-09 | Interim Payment 1.2 INR |
2021-11-16 | Interim Payment 0.8 INR |
2021-05-10 | Interim Payment 0.8 INR |
2021-02-07 | Interim Payment 0.4 INR |
2020-11-09 | Interim Payment 0.8 INR |
2020-06-30 | Final Payment 1 INR |
2020-03-22 | Interim Payment 1.5 INR |
2019-07-02 | Annual 1.5 INR |
2018-06-27 | Annual 1.5 INR |
2017-07-05 | Annual 1.5 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 49 356 49 042 0.64% | 60 406 62 705 -3.67% | 50 408 50 565 -0.31% | 55 090 | 64 501 | 74 882 |
EBITDA Million INR | Released Forecast Spread | 14 224 14 580 -2.44% | 15 922 17 202 -7.44% | 7 775 8 114 -4.18% | 10 339 | 14 489 | 17 951 |
EBIT Million INR | Released Forecast Spread | 11 709 12 521 -6.49% | 12 681 13 835 -8.34% | 3 929 4 373 -10.14% | 6 059 | 9 919 | 12 674 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 10 839 10 738 0.93% | 11 089 12 529 -11.49% | 2 364 2 675 -11.64% | 4 440 | 8 121 | 11 050 |
Net income Million INR | Released Forecast Spread | 8 275 8 175 1.22% | 7 901 9 043 -12.63% | 1 606 1 949 -17.62% | 3 230 | 5 991 | 8 168 |
EPS INR | Released Forecast Spread | 15,4 15,2 0.9% | 14,6 16,9 -13.24% | 2,97 3,56 -16.59% | 6,19 | 10,9 | 15,2 |
Announcement Date | 28/04/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 15 759 16 583 -4.97% | 15 448 15 154 1.94% | 13 809 14 558 -5.14% | 11 818 13 313 -11.23% | 12 245 13 633 -10.19% | 11 949 13 597 -12.12% | 14 397 14 331 0.46% | 11 949 13 820 -13.54% | 12 772 | 13 228 | 15 480 | 14 696 | 14 565 | 16 021 |
EBITDA Million INR | Released Forecast Spread | 4 489 4 902 -8.43% | 4 036 4 136 -2.43% | 2 855 3 495 -18.3% | 1 667 2 715 -38.59% | 1 879 2 650 -29.08% | 1 814 2 648 -31.49% | 2 415 2 690 -10.22% | 1 712 2 366 -27.63% | 2 115 | 2 369 | 3 714 | |||
EBIT Million INR | Released Forecast Spread | 3 671 4 343 -15.47% | 3 191 3 016 5.83% | 1 985 3 055 -35.01% | 762 2 267 -66.4% | 945 1 888 -49.95% | 830 2 082 -60.12% | 1 392 1 922 -27.56% | 651 1 537 -57.61% | 976 | 1 428 | 2 506 | 2 131 | 2 221 | 2 563 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 281 4 216 -22.18% | 2 779 2 942 -5.55% | 1 471 2 812 -47.66% | 406 1 779 -77.19% | 539 1 567 -65.6% | 346 1 710 -79.75% | 1 073 1 307 -17.95% | 185 1 225 -84.92% | 539 | 993 | 2 168 | |||
Net income Million INR | Released Forecast Spread | 2 328 2 979 -21.86% | 2 030 2 118 -4.15% | 1 030 2 064 -50.1% | 249 1 035 -75.98% | 370 1 055 -64.97% | 231 1 016 -77.21% | 756 884 -14.43% | 125 685 -81.74% | 294 | 645 | 1 493 | |||
EPS INR | Released Forecast Spread | 4,32 5,85 -26.15% | 3,76 3,50 7.43% | 1,90 3,80 -50% | 0,46 3,00 -84.67% | 0,68 2,60 -73.85% | 0,43 2,00 -78.5% | 1,40 1,40 0% | 0,23 2,10 -89.05% | 1,00 | 1,70 | ||||
Announcement Date | 21/10/22 | 30/01/23 | 27/04/23 | 27/07/23 | 20/10/23 | 24/01/24 | 25/04/24 | 25/07/24 | - | - | - | - | - | - |
Past sector events for Laurus Labs Limited
2025-03-14 | TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.: Q4 2024 Earnings Release |
2025-03-14 02:30 am | DERMAPHARM HOLDING SE: Q4 2024 Earnings Release |
2025-03-13 | PHARMANUTRA S.P.A.: Q4 2024 Earnings Release |
2025-03-13 02:00 am | PHARMING GROUP N.V.: Q4 2024 Earnings Release |
2025-03-12 | CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: Q4 2024 Earnings Release |
2025-03-12 | GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.: Q4 2024 Earnings Release |
2025-03-11 | GRAND PHARMACEUTICAL GROUP LIMITED: Q4 2024 Earnings Release |
2025-03-11 06:20 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q4 2024 Earnings Release |
2025-03-11 01:55 am | POLYPEPTIDE GROUP AG: Q4 2024 Earnings Release |
2025-03-10 | CENTER LABORATORIES, INC.: Q4 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LAURUSLABS Stock
- Calendar Laurus Labs Limited